0

530697

ZENLABS

img img img img
No Data Available

Zenlabs Ethica Limited Share Price Update

As of the latest trading session, Zenlabs Ethica Limited is trading at ₹25.69, down by ₹-0.79 or -2.98% from its previous close. The stock has moved between ₹24.11 and ₹26.38 today. Over the past year, the stock has delivered a return of -27.04%. In the last month, it has returned 31.83%.

Investment Returns

Over 1 Month 31.83% Over 3 Months 16.77% Over 6 Months -22.50% Over 1 Year -27.04%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Zenlabs Ethica Limited fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 16.40
  • P/E Ratio (TTM) -9.33
  • Beta 1.18
  • Book Value / share 16.20
  • Return on equity 2.63%
  • EPS (TTM) 0.36
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -2.01
info icon alternate text

Zenlabs Ethica Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 12.43
Operating Expense 12.37
Net Profit -2.01
Net Profit Margin (%) -16.17
Earnings Per Share (EPS) -3.08
EBITDA -1.54
Effective Tax Rate (%) 0.49
Particulars SEP 2025 (Values in Cr)
Revenue 12.43
Operating Expense 12.42
Net Profit 0.04
Net Profit Margin (%) 0.32
Earnings Per Share (EPS) 0.06
EBITDA 0.51
Effective Tax Rate (%) 50.00
Particulars JUN 2025 (Values in Cr)
Revenue 11.48
Operating Expense 11.44
Net Profit 0.03
Net Profit Margin (%) 0.26
Earnings Per Share (EPS) 0.05
EBITDA 0.54
Effective Tax Rate (%) 25.00
Particulars MAR 2025 (Values in Cr)
Revenue 12.99
Operating Expense 12.87
Net Profit 0.09
Net Profit Margin (%) 0.69
Earnings Per Share (EPS) 0.14
EBITDA 0.70
Effective Tax Rate (%) 37.50
Particulars DEC 2024 (Values in Cr)
Revenue 12.72
Operating Expense 12.60
Net Profit 0.09
Net Profit Margin (%) 0.70
Earnings Per Share (EPS) 0.13
EBITDA 0.69
Effective Tax Rate (%) 30.76
Particulars MAR 2025 (Values in Cr)
Revenue 51.42
Operating Expense 51.05
Net Profit 0.27
Net Profit Margin (%) 0.52
Earnings Per Share (EPS) 0.41
EBITDA 2.62
Effective Tax Rate (%) 37.20
Particulars MAR 2024 (Values in Cr)
Revenue 58.56
Operating Expense 58.28
Net Profit 0.42
Net Profit Margin (%) 0.71
Earnings Per Share (EPS) 0.65
EBITDA 2.70
Effective Tax Rate (%) 27.58
Particulars MAR 2023 (Values in Cr)
Revenue 66.89
Operating Expense 65.76
Net Profit 0.49
Net Profit Margin (%) 0.73
Earnings Per Share (EPS) 0.75
EBITDA 2.45
Effective Tax Rate (%) 28.35
Particulars MAR 2022 (Values in Cr)
Revenue 69.09
Operating Expense 67.91
Net Profit 0.82
Net Profit Margin (%) 1.18
Earnings Per Share (EPS) 1.26
EBITDA 2.52
Effective Tax Rate (%) 34.92
Particulars MAR 2021 (Values in Cr)
Revenue 56.64
Operating Expense 55.83
Net Profit 0.83
Net Profit Margin (%) 1.46
Earnings Per Share (EPS) 1.41
EBITDA 1.23
Effective Tax Rate (%) 9.78
Particulars MAR 2025 (Values in Cr)
Book Value / Share 16.01
ROE % 2.63
ROCE % 5.32
Total Debt to Total Equity 1.34
EBITDA Margin 5.10
Particulars MAR 2024 (Values in Cr)
Book Value / Share 15.55
ROE % 4.24
ROCE % 6.51
Total Debt to Total Equity 1.04
EBITDA Margin 4.63
Particulars MAR 2023 (Values in Cr)
Book Value / Share 14.91
ROE % 9.46
ROCE % 11.42
Total Debt to Total Equity 0.51
EBITDA Margin 4.54
Particulars MAR 2022 (Values in Cr)
Book Value / Share 14.34
ROE % 8.72
ROCE % 12.25
Total Debt to Total Equity 0.36
EBITDA Margin 3.59
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.16
ROE % 9.64
ROCE % 11.52
Total Debt to Total Equity 0.21
EBITDA Margin 3.28
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.79
Total Assets 40.62
Total Liabilities 40.62
Total Equity 10.42
Share Outstanding 0
Price to Book Ratio 1.95
Return on Assets (%) 0.66
Return on Capital (%) 1.21
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.92
Total Assets 40.25
Total Liabilities 40.25
Total Equity 10.12
Share Outstanding 0
Price to Book Ratio 2.67
Return on Assets (%) 1.04
Return on Capital (%) 1.82
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.63
Total Assets 43.49
Total Liabilities 43.49
Total Equity 9.70
Share Outstanding 0
Price to Book Ratio 4.63
Return on Assets (%) 1.12
Return on Capital (%) 3.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.50
Total Assets 37.89
Total Liabilities 37.89
Total Equity 9.33
Share Outstanding 0
Price to Book Ratio 1.99
Return on Assets (%) 2.06
Return on Capital (%) 7.31
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.69
Total Assets 32.20
Total Liabilities 32.20
Total Equity 8.56
Share Outstanding 0
Price to Book Ratio 1.61
Return on Assets (%) 2.38
Return on Capital (%) 8.58
Particulars MAR 2025 (Values in Cr)
Net Income 0.42
Cash from Operations 4.04
Cash from Investing 0.13
Cash from Financing -3.08
Net change in Cash 0.88
Free Cash Flow 4.06
Particulars MAR 2024 (Values in Cr)
Net Income 0.58
Cash from Operations -8.93
Cash from Investing 0.10
Cash from Financing 8.23
Net change in Cash -0.71
Free Cash Flow -8.90
Particulars MAR 2023 (Values in Cr)
Net Income 0.67
Cash from Operations 1.78
Cash from Investing -1.46
Cash from Financing 0.06
Net change in Cash 0.11
Free Cash Flow 3.33
Particulars MAR 2022 (Values in Cr)
Net Income 1.22
Cash from Operations -0.25
Cash from Investing 0.00
Cash from Financing 0.31
Net change in Cash -0.06
Free Cash Flow -0.23
Particulars MAR 2021 (Values in Cr)
Net Income 0.86
Cash from Operations -8.31
Cash from Investing 0.15
Cash from Financing -0.52
Net change in Cash -8.78
Free Cash Flow -8.31
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.77 1.65 243.69 23.12 40.44
BLISS GVS PHARMA LTD 276.25 26.41 2.58 2922.42 105.05 280.20
CIPLA LTD 1309.90 22.25 3.21 105811.45 1165.55 1672.20
FERMENTA BIOTECH LIMITED 311.40 10.36 2.34 916.48 252.15 399.00
GLAXOSMITHKLINE PHARMA LT 2335.60 39.34 23.16 39566.47 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 30.58 4.43 243.69 23.12 40.44
AMRUTANJAN HEALTH CARE LTD. 570.45 28.52 4.82 1649.21 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8217.20 98.75 25.71 20543.00 7630.00 10653.05
BLISS GVS PHARMA LTD 276.25 37.64 2.64 2922.42 105.05 280.20

Zenlabs Ethica Limited shareholding pattern

Holding
47.03%
52.96%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Zenlabs Ethica Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
25.22 -4.79 redarrow
red-green-graph indicator
1 Bearish
15 Bullish
  • 5 Days 24.30
  • 26 Days 22.30
  • 10 Days 23.60
  • 50 Days 21.60
  • 12 Days 23.40
  • 100 Days 22.30
  • 20 Days 22.70
  • 200 Days 25.10
22.82 PIVOT
First Support 22.17 First Resistance 23.65 Second Support 21.34 Second Resistance 24.30 Third Support 20.69 Third Resistance 25.13
RSI 55.78 ADX 50.17 MACD 0.89 Williams % R -43.75 Commodity Channel Index (CCI) 35.04
Date 2026-04-30 Week 5373.00 Same Day 109.00 Month 6451.00
1 Year 1.10 3 Year 0.75
Over 1 Month
31.83% down
Over 1 Year
-27.04% down
Over 3 Months
16.77% down
Over 3 Years
-24.43% down
Over 6 Months
-22.50% down
Over 5 Years
-0.80% down

Zenlabs Ethica Limited Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
29 Jul 2022 0.25 Interim 01 Aug 2022 Equity shares
20 Sep 2017 0.25 Final 22 Sep 2017 Equity shares
Ex-Date Ex-Bonus Ratio
13 Oct 2018 11 Oct 2018 1:20

Top Gainers

Top Losers

Zenlabs Ethica Limited Share Price

Zenlabs Ethica Limited was initially incorporated in the name of Neelkanth Technologies Limited on 20 July, 1993. With the due approval from the Registrar of Companies, Ministry of Corporate Affairs, name of the Company was changed to Zenlabs Ethica Limited in 2016-17.

The Company is one of the top 10 pharmaceutical contract manufacturing companies in India that develops, markets and exports a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti Hypertensive Drugs, Anti-Infective, Soaps & Anti Bacterial Drugs, Nutraceuticals, etc. The company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada. It offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India.

In 2023, the Company ventured into diversified segments like Neurology and Cytrics.

Parent organization Indian Private
NSE symbol [-]
Founded 1993
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Zenlabs Ethica Ltd?

Answer Field

Zenlabs Ethica Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 25.22 as on May 07 2026 03:28 PM.

What is the Market Cap of Zenlabs Ethica Ltd Share?

Answer Field

The market cap of Zenlabs Ethica Ltd for NSE ₹ 0.00 & for BSE ₹ 16.40 as on May 07 2026 03:28 PM.

What is the 52 Week High and Low of Zenlabs Ethica Ltd?

Answer Field

The 52 Week High and Low of Zenlabs Ethica Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 39.20 and ₹ 16.50.

What is 1 year return for Zenlabs Ethica Ltd?

Answer Field

The 1 year returns on the stock has been -17.19%.

What is the P/E Ratio of Zenlabs Ethica Ltd Share?

Answer Field

As on May 07 2026 03:28 PM the price-to-earnings (PE) ratio for Zenlabs Ethica Ltd share is -9.33.

What is the PB ratio of Zenlabs Ethica Ltd Share?

Answer Field

As on May 07 2026 03:28 PM, the price-to-book (PB) ratio for Zenlabs Ethica Ltd share is 16.20.

How to Buy Zenlabs Ethica Ltd Share?

Answer Field

You can trade in Zenlabs Ethica Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Zenlabs Ethica Ltd Share on Bajaj Broking App?

Answer Field

To buy Zenlabs Ethica Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Zenlabs Ethica Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|